A detailed history of Wellington Management Group LLP transactions in Argenx Se stock. As of the latest transaction made, Wellington Management Group LLP holds 482,346 shares of ARGX stock, worth $272 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
482,346
Previous 426,729 13.03%
Holding current value
$272 Million
Previous $184 Million 42.55%
% of portfolio
0.05%
Previous 0.03%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$434.22 - $551.9 $24.2 Million - $30.7 Million
55,617 Added 13.03%
482,346 $262 Million
Q2 2024

Aug 13, 2024

BUY
$356.01 - $451.55 $53.6 Million - $68 Million
150,557 Added 54.52%
426,729 $184 Million
Q1 2024

May 15, 2024

BUY
$356.95 - $413.29 $98.6 Million - $114 Million
276,172 New
276,172 $109 Million
Q4 2023

Feb 12, 2024

BUY
$338.91 - $506.01 $94.6 Million - $141 Million
279,168 New
279,168 $106 Million
Q3 2023

Nov 14, 2023

SELL
$369.35 - $548.43 $4.74 Million - $7.04 Million
-12,843 Reduced 5.49%
221,212 $109 Million
Q2 2023

Aug 14, 2023

SELL
$360.14 - $422.58 $8.72 Million - $10.2 Million
-24,221 Reduced 9.38%
234,055 $91.2 Million
Q1 2023

May 12, 2023

BUY
$334.23 - $403.65 $12.6 Million - $15.2 Million
37,607 Added 17.04%
258,276 $96.2 Million
Q4 2022

Feb 13, 2023

BUY
$342.17 - $402.31 $1.74 Million - $2.04 Million
5,076 Added 2.35%
220,669 $83.6 Million
Q3 2022

Nov 14, 2022

BUY
$343.2 - $395.75 $56.2 Million - $64.7 Million
163,608 Added 314.72%
215,593 $76.1 Million
Q2 2022

Aug 15, 2022

SELL
$269.58 - $378.88 $50.3 Million - $70.7 Million
-186,526 Reduced 78.2%
51,985 $19.7 Million
Q1 2022

May 16, 2022

SELL
$254.45 - $351.06 $40.8 Million - $56.4 Million
-160,517 Reduced 40.23%
238,511 $75.2 Million
Q4 2021

Feb 11, 2022

SELL
$272.01 - $353.03 $73.4 Million - $95.2 Million
-269,668 Reduced 40.33%
399,028 $140 Million
Q3 2021

Nov 15, 2021

BUY
$295.0 - $350.58 $32.6 Million - $38.7 Million
110,349 Added 19.76%
668,696 $202 Million
Q2 2021

Aug 16, 2021

BUY
$257.11 - $319.92 $10.3 Million - $12.8 Million
39,934 Added 7.7%
558,347 $168 Million
Q1 2021

May 17, 2021

SELL
$268.3 - $380.31 $26.3 Million - $37.3 Million
-98,062 Reduced 15.91%
518,413 $143 Million
Q4 2020

Feb 12, 2021

SELL
$248.13 - $308.36 $110 Million - $137 Million
-443,879 Reduced 41.86%
616,475 $181 Million
Q3 2020

Nov 16, 2020

BUY
$215.51 - $272.51 $91 Million - $115 Million
422,223 Added 66.17%
1,060,354 $278 Million
Q2 2020

Aug 14, 2020

SELL
$127.44 - $232.72 $6.42 Million - $11.7 Million
-50,411 Reduced 7.32%
638,131 $144 Million
Q1 2020

May 14, 2020

BUY
$108.83 - $165.23 $40.5 Million - $61.5 Million
372,436 Added 117.82%
688,542 $90.7 Million
Q4 2019

Feb 11, 2020

BUY
$106.59 - $164.21 $33.7 Million - $51.9 Million
316,106 New
316,106 $50.7 Million

Others Institutions Holding ARGX

About ARGENX SE


  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $31.2B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Wellington Management Group LLP Portfolio

Follow Wellington Management Group LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.